Diekema.ppt [Compatibility Mode] - Institute of Medicine

Attributable risk (per 100,000 doses)
Updated Attributable Risk of Febrile Seizures by
Age Group and Concomitant PCV13
100
80
60
40
20
0
-20
23.2
0.0
6.02
42.1
9.7
5.04
9.4
▲ TIV + PCV13**
u TIV**
n PCV13 **
0.5 -1.0
6-11 months 12-23 months 24-59 months
Cases Risk* 6 0 5 9 5 6 2 3 0
Cases Control* 4 0 6 5 3 8 1 9 3
Vaccinees 20,917 19,458 42,088 17,999 42,67856,747 18,28186,841 65,503
* Duration 2 days for risk interval vs. 7 days for control interval
**+/- other vaccines Tokars. ACIP June 2011